BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 11222087)

  • 1. 2,3,7,8-Tetrachlorodibenzo-p-dioxin affects the number and function of murine splenic dendritic cells and their expression of accessory molecules.
    Vorderstrasse BA; Kerkvliet NI
    Toxicol Appl Pharmacol; 2001 Mar; 171(2):117-25. PubMed ID: 11222087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of TC-1 cytokine production, effector cytotoxic T lymphocyte development and alloantibody production by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Kerkvliet NI; Baecher-Steppan L; Shepherd DM; Oughton JA; Vorderstrasse BA; DeKrey GK
    J Immunol; 1996 Sep; 157(6):2310-9. PubMed ID: 8805628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of 2,3,7,8-tetrachlorodibenzo-p-dioxin on the antigen-presenting activity of dendritic cells.
    Vorderstrasse BA; Dearstyne EA; Kerkvliet NI
    Toxicol Sci; 2003 Mar; 72(1):103-12. PubMed ID: 12604839
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aryl hydrocarbon receptor activation affects the dendritic cell phenotype and function during allergic sensitization.
    Schulz VJ; van Roest M; Bol-Schoenmakers M; van Duursen MB; van den Berg M; Pieters RH; Smit JJ
    Immunobiology; 2013 Aug; 218(8):1055-62. PubMed ID: 23433705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-CD40 Treatment of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-exposed C57Bl/6 mice induces activation of antigen presenting cells yet fails to overcome TCDD-induced suppression of allograft immunity.
    Shepherd DM; Steppan LB; Hedstrom OR; Kerkvliet NI
    Toxicol Appl Pharmacol; 2001 Jan; 170(1):10-22. PubMed ID: 11141351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2,3,7,8-Tetrachlorodibenzo-p-dioxin modulates functional differentiation of mouse bone marrow-derived dendritic cells Downregulation of RelB by 2,3,7,8-tetrachlorodibenzo-p-dioxin.
    Lee JA; Hwang JA; Sung HN; Jeon CH; Gill BC; Youn HJ; Park JH
    Toxicol Lett; 2007 Aug; 173(1):31-40. PubMed ID: 17681673
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of altered B7 expression in dioxin immunotoxicity: B7 transfection restores the CTL but not the autoantibody response to the P815 mastocytoma.
    Prell RA; Kerkvliet NI
    J Immunol; 1997 Mar; 158(6):2695-703. PubMed ID: 9058803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of TCDD on the fate of naive dendritic cells.
    Bankoti J; Burnett A; Navarro S; Miller AK; Rase B; Shepherd DM
    Toxicol Sci; 2010 Jun; 115(2):422-34. PubMed ID: 20211938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunotoxic effects of dual exposure to PCP and TCDD.
    Chen HM; Lee YH; Chen RJ; Chiu HW; Wang BJ; Wang YJ
    Chem Biol Interact; 2013 Nov; 206(2):166-74. PubMed ID: 24051191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aryl hydrocarbon receptor-deficient mice generate normal immune responses to model antigens and are resistant to TCDD-induced immune suppression.
    Vorderstrasse BA; Steppan LB; Silverstone AE; Kerkvliet NI
    Toxicol Appl Pharmacol; 2001 Mar; 171(3):157-64. PubMed ID: 11243915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells.
    Castellaneta A; Abe M; Morelli AE; Thomson AW
    Hum Immunol; 2004 Feb; 65(2):104-13. PubMed ID: 14969765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T lymphocytes are direct, aryl hydrocarbon receptor (AhR)-dependent targets of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD): AhR expression in both CD4+ and CD8+ T cells is necessary for full suppression of a cytotoxic T lymphocyte response by TCDD.
    Kerkvliet NI; Shepherd DM; Baecher-Steppan L
    Toxicol Appl Pharmacol; 2002 Dec; 185(2):146-52. PubMed ID: 12490139
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and behavior of the Ah receptor in murine T lymphocytes.
    Lawrence BP; Leid M; Kerkvliet NI
    Toxicol Appl Pharmacol; 1996 Jun; 138(2):275-84. PubMed ID: 8658529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early consequences of 2,3,7,8-tetrachlorodibenzo-p-dioxin exposure on the activation and survival of antigen-specific T cells.
    Funatake CJ; Dearstyne EA; Steppan LB; Shepherd DM; Spanjaard ES; Marshak-Rothstein A; Kerkvliet NI
    Toxicol Sci; 2004 Nov; 82(1):129-42. PubMed ID: 15310856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CTL hyporesponsiveness induced by 2,3,7, 8-tetrachlorodibenzo-p-dioxin: role of cytokines and apoptosis.
    Prell RA; Dearstyne E; Steppan LG; Vella AT; Kerkvliet NI
    Toxicol Appl Pharmacol; 2000 Aug; 166(3):214-21. PubMed ID: 10906285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor-dependent suppression by 2,3,7, 8-tetrachlorodibenzo-p-dioxin of IgM secretion in activated B cells.
    Sulentic CE; Holsapple MP; Kaminski NE
    Mol Pharmacol; 1998 Apr; 53(4):623-9. PubMed ID: 9547351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional and phenotypic effects of AhR activation in inflammatory dendritic cells.
    Bankoti J; Rase B; Simones T; Shepherd DM
    Toxicol Appl Pharmacol; 2010 Jul; 246(1-2):18-28. PubMed ID: 20350561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elucidation of cellular targets responsible for tetrachlorodibenzo-p-dioxin (TCDD)-induced suppression of antibody responses: II. The role of the T-lymphocyte.
    Dooley RK; Morris DL; Holsapple MP
    Immunopharmacology; 1990; 19(1):47-58. PubMed ID: 2307581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Consequences of AhR activation in steady-state dendritic cells.
    Simones T; Shepherd DM
    Toxicol Sci; 2011 Feb; 119(2):293-307. PubMed ID: 21097750
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of constitutively-active aryl hydrocarbon receptor in T-cells enhances the down-regulation of CD62L, but does not alter expression of CD25 or suppress the allogeneic CTL response.
    Funatake CJ; Ao K; Suzuki T; Murai H; Yamamoto M; Fujii-Kuriyama Y; Kerkvliet NI; Nohara K
    J Immunotoxicol; 2009 Sep; 6(3):194-203. PubMed ID: 19635034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.